Travere Therapeutics Inc
NASDAQ:TVTX

Watchlist Manager
Travere Therapeutics Inc Logo
Travere Therapeutics Inc
NASDAQ:TVTX
Watchlist
Price: 18.47 USD -0.48% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
Travere Therapeutics Inc?
Write Note

Travere Therapeutics Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Travere Therapeutics Inc
Long-Term Debt Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Travere Therapeutics Inc
NASDAQ:TVTX
Long-Term Debt
$310m
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
22%
Abbvie Inc
NYSE:ABBV
Long-Term Debt
$58.5B
CAGR 3-Years
-8%
CAGR 5-Years
12%
CAGR 10-Years
15%
Gilead Sciences Inc
NASDAQ:GILD
Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Long-Term Debt
$56.9B
CAGR 3-Years
20%
CAGR 5-Years
15%
CAGR 10-Years
6%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Long-Term Debt
$114m
CAGR 3-Years
-39%
CAGR 5-Years
-27%
CAGR 10-Years
-18%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Long-Term Debt
$2.7B
CAGR 3-Years
11%
CAGR 5-Years
31%
CAGR 10-Years
17%

See Also

What is Travere Therapeutics Inc's Long-Term Debt?
Long-Term Debt
310m USD

Based on the financial report for Sep 30, 2024, Travere Therapeutics Inc's Long-Term Debt amounts to 310m USD.

What is Travere Therapeutics Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
22%

Over the last year, the Long-Term Debt growth was -18%. The average annual Long-Term Debt growth rates for Travere Therapeutics Inc have been 11% over the past three years , 9% over the past five years , and 22% over the past ten years .

Back to Top